A critical finding in neurodegenerative research reveals how GPNMB protein creates a destructive cycle in Parkinson’s disease. When neurons suffer damage, immune cells initiate a protective response by releasing GPNMB. However, this mechanism backfires—the protein actively facilitates transfer of toxic alpha-synuclein aggregates from damaged cells to healthy neurons, perpetuating damage in a spreading pattern. Laboratory studies demonstrate that blocking GPNMB with antibody treatment successfully halted this pathological progression in experimental conditions. This mechanism explains the characteristic pattern of Parkinson’s advancement through distinct brain regions over time. The discovery provides researchers with a specific molecular target for therapeutic intervention, potentially enabling disease-modifying treatments that interrupt the propagation cycle rather than simply alleviating symptoms.
Was this article helpful?
